Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

NCT05487859 ·Status: WITHDRAWN ·Phase: PHASE2

Study of CP-461 in Patients With Advanced Renal Cell Cancer

NCT00036036 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

NCT00003683 ·Status: COMPLETED ·Phase: PHASE2

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

NCT03013335 ·Status: COMPLETED ·Phase: PHASE2

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

NCT04489771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

NCT00005045 ·Status: COMPLETED ·Phase: PHASE2

Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma

NCT00389285 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

NCT00830895 ·Status: COMPLETED ·Phase: PHASE2

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

NCT02724878 ·Status: COMPLETED ·Phase: PHASE2

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

NCT00293501 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer

NCT02089334 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

NCT03291028 ·Status: ACTIVE_NOT_RECRUITING

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

NCT00891475 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

NCT02848768 ·Status: COMPLETED

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

NCT01100242 ·Status: TERMINATED ·Phase: PHASE2

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07218692 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974 ·Status: COMPLETED ·Phase: PHASE2

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

NCT01984242 ·Status: COMPLETED ·Phase: PHASE2

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

NCT00445042 ·Status: COMPLETED ·Phase: PHASE2

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

NCT00003390 ·Status: COMPLETED ·Phase: PHASE2

BAY 59-8862 in Treating Patients With Advanced Kidney Cancer

NCT00039169 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

NCT02187042 ·Status: COMPLETED

A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer

NCT02982954 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

NCT00422019 ·Status: COMPLETED ·Phase: PHASE2

SU011248 in Advanced Hepatocellular Carcinoma

NCT00361309 ·Status: COMPLETED ·Phase: PHASE2